Drug Interaction of Vildagliptin (LAF237) With Voglibose in Japanese Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study will evaluate the effect of voglibose on the pharmacokinetics and pharmacodynamics
of vildagliptin in Japanese patients with type 2 diabetes.